CV Sciences (CVSI) Work In Process (2013 - 2026)

CV Sciences (CVSI) reported Work In Process of $414000.0 for Q1 2026, down 29.83% on a YoY basis from $590000.0 in Q1 2025, and up 6.98% sequentially from $387000.0 in Q4 2025.

CV Sciences (CVSI) Work In Process (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 10 years of Work In Process data on file, last reported at $414000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Work In Process fell 29.83% year-over-year to $414000.0; the trailing twelve-month figure through Mar 2026 stood at $414000.0 (down 29.83% YoY), and the FY2025 full-year result was $387000.0, down 40.37% from the prior year.
  • Work In Process rose to $414000.0 in Q1 2026, from $387000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.6 million in Q2 2022 to a low of $356000.0 in Q3 2025.
  • A 5-year average of $949764.7 and a median of $1.2 million in 2023 frame the typical range for Work In Process.
  • Across the five-year window, Work In Process increased 23.99% in 2022 and tumbled 69.68% in 2025, its largest moves.
  • Tracing CVSI's Work In Process over 5 years: stood at $1.0 million in 2022, then rose by 15.78% to $1.2 million in 2023, then plunged by 45.05% to $649000.0 in 2024, then tumbled by 40.37% to $387000.0 in 2025, then rose by 6.98% to $414000.0 in 2026.
  • Business Quant data shows CVSI's Work In Process at $414000.0 in Q1 2026, $387000.0 in Q4 2025, and $356000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 414,000.00
Dec 31, 2025 387,000.00
Sep 30, 2025 356,000.00
Jun 30, 2025 381,000.00
Mar 31, 2025 590,000.00
Dec 31, 2024 649,000.00
Sep 30, 2024 1.17 Mn
Jun 30, 2024 836,000.00
Mar 31, 2024 1.29 Mn
Dec 31, 2023 1.18 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.19 Mn
Mar 31, 2023 1.15 Mn
Dec 31, 2022 1.02 Mn
Sep 30, 2022 1.22 Mn
Jun 30, 2022 1.61 Mn
Mar 31, 2022 1.39 Mn
Dec 31, 2021 1.29 Mn
Sep 30, 2021 1.52 Mn
Jun 30, 2021 1.69 Mn